Correlation Between Cingulate and Cadrenal Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Cingulate and Cadrenal Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate and Cadrenal Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate and Cadrenal Therapeutics, Common, you can compare the effects of market volatilities on Cingulate and Cadrenal Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate with a short position of Cadrenal Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate and Cadrenal Therapeutics,.
Diversification Opportunities for Cingulate and Cadrenal Therapeutics,
-0.78 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Cingulate and Cadrenal is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate and Cadrenal Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cadrenal Therapeutics, and Cingulate is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate are associated (or correlated) with Cadrenal Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cadrenal Therapeutics, has no effect on the direction of Cingulate i.e., Cingulate and Cadrenal Therapeutics, go up and down completely randomly.
Pair Corralation between Cingulate and Cadrenal Therapeutics,
Given the investment horizon of 90 days Cingulate is expected to generate 1.21 times more return on investment than Cadrenal Therapeutics,. However, Cingulate is 1.21 times more volatile than Cadrenal Therapeutics, Common. It trades about 0.01 of its potential returns per unit of risk. Cadrenal Therapeutics, Common is currently generating about -0.03 per unit of risk. If you would invest 439.00 in Cingulate on August 30, 2024 and sell it today you would lose (19.00) from holding Cingulate or give up 4.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cingulate vs. Cadrenal Therapeutics, Common
Performance |
| Timeline |
| Cingulate |
| Cadrenal Therapeutics, |
Cingulate and Cadrenal Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cingulate and Cadrenal Therapeutics,
The main advantage of trading using opposite Cingulate and Cadrenal Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate position performs unexpectedly, Cadrenal Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cadrenal Therapeutics, will offset losses from the drop in Cadrenal Therapeutics,'s long position.| Cingulate vs. SAB Biotherapeutics | Cingulate vs. Senti Biosciences | Cingulate vs. Aerovate Therapeutics | Cingulate vs. Adagene |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |